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sag We examined the diurnal sleep-wake patterns in the adjuvant arthritic rat. In contrast to control rats, ar’thritic rats 
lacked a normal diurnal variation in sleep and wakefulness. Thus, arthritic rats exhibited no differences in the mean number or 
duration of bouts of sleep and episodes of wakefulness between light and dark hours. Arthritic rats also had a marked increase in the 
fragmentation of their sleep manifested by an increased number of sleep bouts and episodes of wakefulness and a decrease in the 
duration of episodes of deep sleep recorded both during the time of maximal sleep (08.00-11.00 h) and of maximal wakefulness 
(20.~-23.~ h). The possibiity that the experience of chronic pain causes these marked changes in sleep patterns in the arthritic rat 
is discussed. 
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Introduction 
Patients with arthritis frequently complain of 
difficulty falling asleep and of frequent awaken- 
ings during the night [21,34]. Electroencephalo- 
gram (EEG) studies of sleep patterns show that 
patients with rheumatoid arthritis take a longer 
time to fall asleep, have reduced sleep, and have 
frequent episodes of awakening after sleep onset 
127,301. They have an additional sleep disturbance 
characterized on the EEG by the presence of 
alpha frequency waveforms during non-rapid eye 
movement (Nap) sleep stages [27,30]. This 
nocturnal EEG arousal pattern, called alpha- 
NREM sleep, has been associated with reports of 
increased pain, tenderness, weakness, and fatigue 
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[30]. It is unclear whether these sleep disturbances 
associated with rheumatoid arthritis are caused by 
pain, and/or by other aspects of this systemic 
disease. For example, periodic extremity move- 
ments [27] and psychological distress also cause 
disrupted sleep [21] and may contribute to the 
abnormal sleep patterns in patients with arthritis. 
Thus, it has been difficult to establish in patients 
with arthritis that pain is a cause of their sleep 
disturb~ces. 
Adjuvant arthritis in the rat, a disease model of 
chronic pain [7,8], is associated with hyperalgesia 
[7,8,10,17,18,23,26,33]. The h~er~gesia is highest 
when pain-related behaviors are most pronounced 
[7,17]. Arthritic rats have significantly more sleep 
preparatory (resting) behaviors without a signifi- 
cant increase in sleep [173. These data suggest that 
arthritic rats may have a fragmented pattern of 
sleep similar to that observed in patients with 
rheumatoid arthritis. The possibility that pain may 
cause disrupted sleep in arthritic rats is suggested 
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by the fact that the elimination of pain in these 
rats reduces signs of morbidity [14]. Although 
many studies document dramatic changes in the 
behavior of arthritic rats, no studies have quanti- 
fied changes in EEG sleep patterns. In the present 
study we describe a loss of diurnal variations in 
sleep and wake stages and a fra~entation in 
sleep patterns in rats produced by the induction of 
experimental arthritis. 
Methods 
Surgical preparation and recordings 
The experiments were performed on male 
Sprague-Dawley rats (250-350 g; Bantin and 
Kingman, Fremont, CA). To record EEG and 
EEG-theta sleep patterns [2], rats were anesthe- 
tized with sodium pentobarbital (50 mg/kg) and 
stainless steel wire electrodes were placed on the 
dura through holes drilled in the skull. To record 
electromyographic (EM@ activity, 2 silver wires 
were placed under each temporalis muscle 1351. All 
electrodes were secured to the skull with dental 
acrylic. Prior to recording sessions, a cable was 
attached to the electrodes and the rats were placed 
in Plexiglas cages (12 cm X 21 cm floor, 15 cm 
high), located in a sound attenuated recording 
chamber. The ambient temperature of the Plexi- 
glas cages was 23°C (&2”(Z). Throughout the 
experiments, including time in home cages and 
recording chambers, rats were maintained on a 12 
h light-dark schedule with lights on at 08.00 h. 
Food and water were available ad lib. 
When rats are adapted to this 12 h light-dark 
cycle, they typically demonstrate a diurnal pattern 
of sleep and wakefulness. Rats sleep most during 
the first 3 h of the light period (08.00-11.00) and 
least during the first 3 h of the dark period 
(20.00-23.00) [6,29]. Accordingly, sleep and wake 
patterns were recorded for 3 h at the beginning of 
the light period and again at the beginning of the 
dark period. Rats were aIlowed I week to recover 
from surgery and 1 day to adapt to the recording 
cage. After 2 baseline recording days, rats were 
arthritized. Arthritic rats were allowed to readapt 
to the recording chamber on the third day after 
the onset of clinical signs of arthritis and sleep 
patterns were recorded again for 2 days. 
Temperature 
Since changes in body temperature can affect 
sleep 120,223 and since elevations of body tempera- 
ture have been reported in arthritic rats [9], core 
temperature was recorded in 12 non-arthritic and 
11 arthritic rats. Rats had a small thermally sensi- 
tive transmitter (Mix-utter, Model VM, Sun 
River, OR, U.S.A.) surgically inserted into the 
peritoneal cavity at the same time that EEG and 
EMG electrodes were implanted [16]. Body tem- 
perature was recorded at 07.00 h, 10.00 h, 13.00 h, 
19.00 h and 22.00 h on the days that sleep record- 
ings were made. Core body temperatures recorded 
at 10.00 h and 22.00 h, the time of a large dif- 
ference in body temperature of normal rats [15], 
were used for statistical comparison. 
Scoring of sleep stages 
Polygraph recordings of EEGs were divided 
into consecutive 30 set segments of time, called 
epochs. Each epoch was then scored, blind, into 
wakefulness or 1 of 4 sleep stages according to the 
classification of Mistlberger et al, 1291. The latter 
scales distinguish wakefulness (Wake), low-ampli- 
tude NREM sleep (NREM-LS), high-amplitude 
NREM sleep 1 (NREM-HSl), ~~-amplitude 
NREM sleep 2 (NREM-HS2), and paradoxical 
sleep (PS, also called rapid eye movement (REM) 
sleep). The waking state was defined by a low-am- 
plitude, fast frequency EEG a~ompa~ed by 
high-amplitude tonic and phasic EMG activity. 
NREM-LS (a transition stage from wakefulness to 
sleep and from one sleep stage to another) was 
differentiated from wakefulness by a decrease in 
the tonic and an absence of phasic EMG activity. 
NREM-HSl was scored as present when the am- 
plitude of the EEG was high and the amplitude of 
the EMG was low for 30-50% of a 30 set segment 
of time (epoch). NREM-HS2 (also called slow- 
wave sleep) was scored when these same EEG and 
EMG patterns were present for more than 50% of 
an epoch. PS was defined by a low-amplitude 
EEG, a higher amplitude of EEG-theta activity 
than that of wakefulness, and the absence of EMG 
activity, with the exception of occasional muscle 
twitches. 
Sleep bouts and sleep stage episodes were mea- 
sured for each 3 h of EEG recordings in order to 
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characterize fragmentation in the pattern of sleep. 
Sleep bouts were uninterrupted periods of sleep 
time. The number and duration of sleep bouts 
were measured as consecutive 30 set epochs con- 
taining NREM-LS, NREM-HSl, NREM-HM, 
and PS that occurred between at least 2 consecu- 
tive epochs (1 min) of wakefulness [29]. Sleep and 
wake stage episodes are the number of times an 
individual sleep or wake stage occurred during a 3 
h recording period. Stage episodes were measured 
as the number of times consecutive epochs of each 
stage were scored during a 3 h period of EEG 
recordings. The mean duration of an episode was 
calculated by dividing the sum of all the epochs of 
a stage scored in a 3 h period of time by the 
number of times that stage occurred in the same 
time period (the number of episodes of the stage). 
Arthritis 
Adjuvant arthritis was induced in all rats by the 
intradermal injection of 0.15 ml of a 10 mg/ml 
suspension of heat-killed Mycobacterium butyri- 
cum (Difco, Detroit, MI, U.S.A.) in mineral oil, in 
the tail [32]. This preparation elicits a bilateral, 
distal arthritis that usually affects the hind paws 
more severely than the forepaws. Onset of clini- 
cally apparent arthritis (swelling and tenderness in 
the paws) occurs approximately 2 weeks after the 
injection of adjuvant. The disease remains active 
for at least 2 weeks [7,33]. The mean onset of 
arthritis in 7 rats was 13.7 f 2.1 days (X + 1 S.D.). 
To monitor severity of the disease, a O-3 rating 
scale was used in which 0 = no signs of swelling, 
1 = minimal, 2 = moderate, and 3 = severe swel- 
ling [14]. The scores for swelling were measured 
daily in each paw beginning on post-injection day 
10. The score for each paw was summed to yield a 
daily clinical score of illness severity (range O-12) 
for each rat. The daily clinical scores for each rat 
were averaged for the 2 days that the sleep EEG 
was recorded. The average clinical severity score 
in 7 rats was 3.21 + 1.8 (X f 1 S.D., range 1.5-7.0). 
The clinical scores measured on the day following 
the completion of sleep recordings in arthritic rats 
correlated significantly (r = 0.8907, P c 0.01) with 
scores of severity of joint injury derived from 
whole body radiographs taken on the same day. 
Radiographic scores of each paw were determined 
independently by a skeletal radiologist using the 
rating scale of Ackerman et al. [l] in which 0 
indicated no joint injury, 1 = mild, 2 = moderate, 
and 3 = severe joint injury. 
This study followed the IASP guidelines for 
investigating experimental pain in animals [13]. 
The duration of the experiment was kept to a 
minimum and the number of animals used was 
small. The animals were housed with no more 
than 2 rats per cage to reduce the possibility of 
painful contact between them. The floors of the 
recording cages and home cages were covered with 
soft saw dust. Food was available at the level of 
the cage floor, and drinking water was within easy 
reach. 
Statistical analysis 
The paired Wilcoxon signed rank test was used 
to compare the number and duration of sleep 
bouts and sleep and wake stage episodes and the 
paired Student’s t test was used to compare core 
body temperatures in groups of non-arthritic and 
arthritic rats. Data for sleep variables and temper- 
ature are reported as the mean A 1 standard devia- 
tion (X + 1 S.D.). 
Results 
Diurnal variations in sleep patterns 
Non-arthritic rat. Non-arthritic rats had longer 
periods of uninterrupted time asleep during light 
than dark hours. Although the total number of 
sleep bouts did not differ significantly between the 
light (8.6 f 2.95) and dark (7.43 &- 2.3) hours in 
non-arthritic rats (Fig. lA), the mean duration in 
minutes of a sleep bout was significantly longer in 
the light (13.98 + 3.76 min) than the dark (8.56 5 
2.72 min, P < 0.03) hours (Fig. 1B). Non-arthritic 
rats also had significantly more episodes of high- 
amplitude NREM sleep stages (NREM-HSl and 
NREM-HS2) and of paradoxical sleep (PS) in 
light hours (all P -C 0.05, Table I). In addition, the 
duration of NREM-HM sleep stage episodes was 
twice as long in the light hours (P < 0.05). The 
number of wake episodes was not significantly 
different between light and dark hours but the 
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Nonarthritic Arthritic Nonarthritic Arthritic 
Fig. 1. A: the number of sleep bouts during 3 h polygraph 
recordings in light (08.00-11.00 h) and dark (20.00-23.00 h) 
hours (n = 7 rats). B: the mean duration of sleep bouts in 
minutes for the same time periods. Sleep bout duration = sum 
of totaf time in all sleep bouts/total number of sleep bouts in a 
3 h period. 
mean duration of wake episodes was significantly 
longer in the dark hours (P < 0.02, Table II). 
Arthritic rat. In comp~son to the non-~th~tic 
rats, the arthritic rats did not have significant 
differences in the number and/or mean duration 
of sleep bouts between the light (15.5 + 2.3; 5.48 
f 1.28 min) and dark hours (13.98 + 4.4; 5.9 + 
2.41 min, Fig. 1). Furthermore, arthritic rats did 
not have significant differences between light and 
dark hours in the number (Table I) and duration 
(Table II) of episodes of sleep stages and of wake- 
fulness. 
Comparison of arthritic and non-arthritic rat 
The sleep patterns of arthritic rats were more 
fragmented than those of non-arthritic rats. Thus, 
arthritic rats had twice as many sleep bouts as 
non-arthritic rats during both the light (arthritic 
15.5 _+ 2.3, non-arthritic 8.6 f 2.95, P < 0.02) and 
the dark (arthritic 13.98 &- 4.4, non-arthritic 7.43 
f 2.3, P -C 0.03) hours (Fig. 1A). The mean dura- 
tion of these bouts of sleep in arthritic rats was 
also significantly shorter in light hours (arthritic 
5.48 rfr 1.3 min, non-arthritic 13.98 f 3.8 min, P < 
0.02, Fig. 1B). Arthritic rats also had a significant 
increase in the number of wakefulness episodes 
during both the light and dark (P < 0.05 and 
P < 0.03, respectively) hours (Table I) and a sig- 
nificant reduction in the duration of these epi- 
sodes in the dark hours (P -e 0.03, Table II). This 
fragmentation of sleep in arthritic rats was further 
manifested by a significant reduction in the dura- 
tion of episodes of ~~-~phtude NREM sleep 2 
(slow-wave sleep} during light hours (P < 0.02, 
Table II), and a significant increase in the number 
TABLE I 
STAGE EPISODE (number) 
n = 7 rats, mean number of stage episodes f SD. Statistical comparisons are indicated by pairs of letters. Paired Wilcoxon signed 
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of episodes of high-amplitude NREM sleep 1 dur- 
ing the dark hours (P < 0.05, Table I). In ad- 
dition, arthritic rats had a significant increase in 
low-amplitude NREM sleep stage episodes during 
both the light and dark hours (both P < 0.02, 
Table I). However, there were no significant dif- 
ferences in the duration of these episodes (P > 
0.05). 
Temperature variations 
Arthritic rats had a small, albeit significant, 
elevation in core temperature recorded at 10.00 h 
(arthritic rats, 39.6” C f 0.592, n = 11, and non- 
arthritic rats, 38.9”Cf0.61, P<O.Ol, n= 12). 
There was no significant difference in core tem- 
perature recorded at 22.00 h (arthritic rats, 
4’ -I 
36-l I I 
0700 1000 1300 1600 1900 2200 
Hours 
Fig. 2. Changes in core body temperature (X f S.D.) in arthritic 
(0, n = 11) and non-arthritic (0, n = 12) rats. 
40.0 o C f 0.664 and non-arthritic rats, 39.6’ C f 
0.61, P > 0.05, Fig. 2). 
Discussion 
Experimentally induced arthritis in the rat 
produces a fragmented pattern of sleep and wake- 
fulness. During both the time of maximal 
sleep (08.00-11.00 h) and maximal wakefulness 
(20.00-23.00 h), arthritic rats show large increases 
in the number of sleep bouts and episodes of 
wakefulness. The increase in episodes of wakeful- 
ness observed in arthritic rats is consistent with 
prior reports of an increase in the number of 
awakenings in patients with rheumatoid arthritis 
[27,30]. A fragmented pattern of sleep is further 
manifested in arthritic rats by a considerable re- 
duction in the duration of time spent asleep (sleep 
bouts) and in the duration of episodes of high-am- 
plitude NREM sleep 2 (slow-wave sleep) during 
the time of maximal sleep in control rats. 
These findings from EEG recordings of sleep 
patterns in arthritic rats support previous behav- 
ioral observations reporting that arthritic rats en- 
gage in more prodromal sleep behaviors [17]. Thus, 
arthritic rats are repeatedly aroused during the 
hours of maximal sleep and they are more sleepy 
- as indicated by significantly more sleep bouts 
and episodes of high-amplitude NREM sleep 1 - 
during the hours of maximal wakefulness, Frag- 
mented patterns of sleep represent a loss in the 
continuity of sleep and are less restorative than 
non-fragmented sleep f3-51. 
Moldofsky et al. [30] hypothesized that pain is 
the cause of disrupted sleep patterns in patients 
with rheumatoid arthritis, and that this non-re- 
storative sleep, in turn, is the cause of the increase 
in pain and tenderness reported by patients in the 
morning. The possibility that pain is the cause of 
disrupted sleep in arthritic rats is suggested not 
only by the fact that arthritic rats demonstrate 
behavioral signs of chronic pain, but also by the 
fact that the eli~nation of pain in these rats 
reduces the signs of morbidity 1141. 
Considerable evidence exists that adjuvant 
arthritis in the rat is associated with chronic pain 
[7,8]. Arthritic rats lose weight [7,11,12,14,17], hy- 
perventilate [11,12], reduce activity [7,14,17], and 
become irritable and hyperreactive when handled 
[33]. In these rats there is a reduction in vocaliza- 
tion and withdrawal threshold to mechanical paw 
pressure [7,23] and to slight flexion and extension 
of inflamed joints [7,26]. The elimination of most 
of the pain in arthritic rats by surgical lesions of 
the ‘pain transmission’ pathways of the spinal 
cord, which elevates vocalization thresholds, at- 
tenuates the weight loss and decreased activity 
[14]. Arthritic rats also select and develop a prefer- 
ence for solutions containing non-steroidal anti- 
inhalator or low doses of opiate analgesics 
[9,10]. The intake of the opiate solution correlates 
with the time course of pain responses as mea- 
sured by a change in vocalization threshold [lo]. 
Thus, pain is a critical factor producing morbidity 
in arthritic rats and also may be a cause of frag- 
mentation in sleep patterns. 
Two concomitant aspects of arthritis, immobil- 
ity [39] and elevated temperature [20,21], also may 
explain, in part, the fragmentation in sleep pat- 
terns observed in arthritic rats. Healthy humans 
placed at bed rest develop more fragmented sleep 
with frequent awakenings and shorter sleep stage 
episodes. These findings, however, are not con- 
sistent in all studies [see 39 for review]. In fact, the 
results from 2 studies of young healthy adults 
confined to bedrest under a normal day-night 
cycle showed just the opposite, immobility 
decreased episodes of wakefulness and increased 
the number and duration of episodes of NREM 
and REM sleep 131,361. 
Following the administration of pyrogens, both 
increases and decreases in slow-wave sleep and 
REM sleep have been reported [19,20,22,24,25,28, 
37,381. The decreases in these stages of sleep and 
an increase in the number of awakenings were 
associated with the peak of the febrile response 
[20,22,38]. When the elevation of body tempera- 
ture was less than I” C, there were, in fact, no 
significant alterations in sleep patterns [20,22,25, 
281. These data suggest that the small elevation of 
core body temperature observed in arthritic rats in 
this study would have minimal effects upon sleep. 
In summary, experimentally induced arthritis 
in the rat, a model of chronic pain, causes a 
marked fragmentation of sleep and a loss of the 
diurnal variations of sleep and wakefulness. Inter- 
ventions that reduce pain associated with arthritis 
may reduce the fragmentation in the sleep pat- 
terns of arthritic rats. We are currently evaluating 
the effects of several analgesics on sleep patterns 
in the arthritic rat. 
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